HI TECH PHARMACAL CO INC·4

Oct 18, 9:37 AM ET

GOLDWYN MARTIN M 4

4 · HI TECH PHARMACAL CO INC · Filed Oct 18, 2012

Insider Transaction Report

Form 4
Period: 2012-10-16
Transactions
  • Exercise/Conversion

    Common Stock

    2012-10-16$19.59/sh+421$8,247421 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-10-164219,579 total
    Exercise: $19.59From: 2010-11-12Exp: 2019-11-12Common Stock (421 underlying)
  • Other

    Common Stock

    2012-10-164210 total
Footnotes (4)
  • [F1]The shares acquired upon exercise of the options reflected on this form were immediately distributed without consideration to a member or members of Mr. Goldwyn's law firm.
  • [F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
  • [F3]The option became or becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date.
  • [F4]Other than the balance of the option to acquire an aggregate of 9,579 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 78,447 shares of the Company's stock (for total options to acquire an aggegate of 88,026 shares held by the filer). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT